Our study, highlighting correlations with Aβ, tau load, brain volume, and metabolic changes, opens new research directions for therapeutic strategies targeting UPS to reduce protein aggregation and inflammation in AD. The gene discussed is MAPT; the disease is Alzheimer disease.